FLAG Therapeutics, Inc.
PrivateLast Round
Debt
Aug 8, 2017
Total Funding Raised
$550,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FLAG Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was a Debt round in August 2017.
FLAG Therapeutics, Inc. is a clinical-stage biotechnology company that develops small-molecule therapeutics for the treatment of difficult-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FLAG Therapeutics, Inc. Comparables
Compare FLAG Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biodexa Pharmaceuticals PLC | 79% | |
| Laminar Pharmaceuticals | 79% | |
| BrainChild Bio, Inc. | 79% |
For institutional investors. Book with your work email.
FLAG Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 8, 2017 | ||||
| VC Round | Mar 4, 2016 | ||||
| Debt | Mar 25, 2015 |
For institutional investors. Book with your work email.
FLAG Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Carolina Biotechnology Center | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 214% MoM, reaching 1.6K.
- Apr 21, 2026
Monthly visitors increased 34% MoM.
For institutional investors. Book with your work email.
FLAG Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FLAG Therapeutics, Inc.'s valuation, stock price, and market status.
Is FLAG Therapeutics, Inc. a public or private company?
FLAG Therapeutics, Inc. is a private company.
What is the current stock price of FLAG Therapeutics, Inc.?
FLAG Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks FLAG Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FLAG Therapeutics, Inc. worth (valuation)?
Valuation information for FLAG Therapeutics, Inc. is not publicly available.
Can I buy FLAG Therapeutics, Inc. stock?
FLAG Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FLAG Therapeutics, Inc.'s last funding round?
FLAG Therapeutics, Inc.'s most recent funding round was Debt on August 8, 2017.
Who are the main investors in FLAG Therapeutics, Inc.?
Key investors in FLAG Therapeutics, Inc. include North Carolina Biotechnology Center.
Will FLAG Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for FLAG Therapeutics, Inc..
How can I track FLAG Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in FLAG Therapeutics, Inc.'s shares on secondary markets.